New formulations of the codling moth, Cydia pomonella (L.), granulovirus (CpGV) [family Baculoviridae, genus Granulovirus] are commercially available in North America. In field tests on apple (Malus sp. ‘Delicious’), we compared different application strategies for CpGV (Cyd-X, Certis USA, Clovis, CA) used in full-season programs against high pest populations. In replicated single tree plots, three rates (0.073, 0.219, and 0.438 liter ha−1) and application intervals (7, 10, and 14 d) killed 81–99% of larvae in fruit and reduced the number of mature larvae recovered in tree bands by 54–98%. Although the proportion of deep entries declined by 77–98%, the amount of fruit injury was not reduced compared with controls. There was a statistical trend between increasing dosage and spray frequency intervals and virus effectiveness, but no interaction between these factors. In a commercial orchard, we assessed a standard (0.219 liter ha−1) and two reduced rates of the virus (0.146 and 0.073 liter ha−1) applied in a weekly spray program in replicated 0.2-ha blocks. In the first generation, fruit injury was reduced in virus-treated compared with three untreated blocks although the decrease was only significant at the standard rate. Mortality rates of larvae (in fruit) were ≥90%, dose dependent, and comparable with rates observed from individual trees sprayed with equivalent treatments in the previous study. Rates of larval mortality declined at all dosages (81–85%) in the first part of the second generation. Most damage and proportionally less mortality occurred in the upper canopy. High pest pressures and untreated blocks contributed to significant damage and the study was terminated early. These data suggest virus programs can be tailored according to the localized pest pressure, but it may not prevent economic damage in high-pressure situations.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 98 • No. 5